Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of Micrometastases on Prognosis and Survival in Stage I-II Colon Cancer Patients: The EnRoute+ Study

NCT01097265 is registered in ClinicalTrials.gov with Jeroen Bosch Ziekenhuis as lead sponsor.

NCT NCT01097265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01097265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of Micrometastases on Prognosis and Survival in Stage I-II Colon Cancer Patients: The EnRoute+ Study
Lead sponsor
Jeroen Bosch Ziekenhuis
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 31, 2010
Completion date
Not reported
Enrollment
1,500 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer